|Articles|May 15, 2002
Exclusive agreement: CIBA Vision signs deal to license Presby products
Atlanta - CIBA Vision has gained exclusive worldwide marketing rights to Presby Corp.'s scleral expansion implants, incision device, and blades for the treatment of presbyopia and, potentially, glaucoma.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Metformin use associated with reduced incidence of intermediate AMD
2
MeiraGTx Licenses complement-targeted geographic atrophy program from ZipBio
3
Last year in glaucoma at EnVision Summit 2025
4
Looking back at the 2025 EnVision Summit
5
























